title: Thrombohemorrhagic complications of myeloproliferative disorders.
abstract: Myeloproliferative disorders are commonly associated with thrombohemorrhagic manifestations. The current review highlights recent advances in understanding the epidemiology and pathogenetic mechanisms of thrombotic and bleeding complications. Therapeutic modalities and prophylactic interventions corresponding to the specific disease states are also discussed.
authors.affiliation: Department of Hematology, Pappagergiou Hospital, Thessaloniki, Greece.
authors.forename: Emmanouil
authors.initials: E
authors.lastname: Papadakis
authors.forename: Ron
authors.initials: R
authors.lastname: Hoffman
authors.forename: Benjamin
authors.initials: B
authors.lastname: Brenner
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D009196:Myeloproliferative Disorders / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology; D013927:Thrombosis / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology
chemical_list: D000970:Antineoplastic Agents